v3.25.2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023 $ (2,579,537) $ 28 $ 120,859,873 $ (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023   278,558    
Stock-based compensation expense 254,029   254,029  
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs 6,172,623 $ 43 6,172,580  
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs, shares   427,886    
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs 1,229,874 $ 1 1,229,873  
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares   9,967    
Net loss (1,579,820)     (1,579,820)
Ending Balance at Mar. 31, 2024 3,497,169 $ 72 128,516,355 (125,019,258)
Ending Balance, Shares at Mar. 31, 2024   716,411    
Beginning Balance at Dec. 31, 2023 (2,579,537) $ 28 120,859,873 (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023   278,558    
Net loss (2,847,038)      
Ending Balance at Jun. 30, 2024 2,664,958 $ 73 128,951,361 (126,286,476)
Ending Balance, Shares at Jun. 30, 2024   734,836    
Beginning Balance at Mar. 31, 2024 3,497,169 $ 72 128,516,355 (125,019,258)
Beginning Balance, Shares at Mar. 31, 2024   716,411    
Stock-based compensation expense 126,578   126,578  
Issuance of common stock from cashless exercise of Pre-Funded Warrants, Shares   18,425    
Issuance of common stock from cashless exercise of Pre-Funded Warrants   $ 1 (1)  
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs 308,429   308,429  
Net loss (1,267,218)     (1,267,218)
Ending Balance at Jun. 30, 2024 2,664,958 $ 73 128,951,361 (126,286,476)
Ending Balance, Shares at Jun. 30, 2024   734,836    
Beginning Balance at Dec. 31, 2024 $ 7,038,010 $ 149 135,829,493 (128,791,632)
Beginning Balance, Shares at Dec. 31, 2024 1,486,009 1,486,009    
Stock-based compensation expense $ 84,384   84,384  
Issuance of common stock pursuant to the ESPP 24,999   24,999  
Issuance of common stock pursuant to the ESPP, Shares   6,849    
Net loss (1,306,178)     (1,306,178)
Ending Balance at Mar. 31, 2025 5,841,215 $ 149 135,938,876 (130,097,810)
Ending Balance, Shares at Mar. 31, 2025   1,492,858    
Beginning Balance at Dec. 31, 2024 $ 7,038,010 $ 149 135,829,493 (128,791,632)
Beginning Balance, Shares at Dec. 31, 2024 1,486,009 1,486,009    
Net loss $ (2,877,154)      
Ending Balance at Jun. 30, 2025 $ 4,374,492 $ 149 136,043,129 (131,668,786)
Ending Balance, Shares at Jun. 30, 2025 1,492,858 1,492,858    
Beginning Balance at Mar. 31, 2025 $ 5,841,215 $ 149 135,938,876 (130,097,810)
Beginning Balance, Shares at Mar. 31, 2025   1,492,858    
Stock-based compensation expense 104,253   104,253  
Net loss (1,570,976)     (1,570,976)
Ending Balance at Jun. 30, 2025 $ 4,374,492 $ 149 $ 136,043,129 $ (131,668,786)
Ending Balance, Shares at Jun. 30, 2025 1,492,858 1,492,858